Focal segmental glomerulosclerosis and Arrhythmias

Summary:

Arrhythmias is found among people with Focal segmental glomerulosclerosis, especially for people who are male, 60+ old.

The study analyzes which people have Arrhythmias with Focal segmental glomerulosclerosis. It is created by eHealthMe based on reports of 23 people who have Focal segmental glomerulosclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Focal segmental glomerulosclerosis?

Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli) is found to be associated with 176 drugs and 397 conditions by eHealthMe. Check the latest studies of Focal segmental glomerulosclerosis.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,760 drugs and 4,837 conditions by eHealthMe. Check the latest studies of Arrhythmias.



On Jul, 29, 2026

23 people who have Focal Segmental Glomerulosclerosis and Arrhythmias are studied.

Would you have Arrhythmias when you have Focal segmental glomerulosclerosis?

Gender of people who have Focal Segmental Glomerulosclerosis and experienced Arrhythmias *:

  • female: 37.5 %
  • male: 62.5 %

Age of people who have Focal Segmental Glomerulosclerosis and experienced Arrhythmias *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 33.33 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common co-existing conditions for these people *:

  1. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 4 people, 17.39%
  2. Iron Deficiency: 1 person, 4.35%
  3. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 4.35%

Common drugs taken by these people *:

  1. Acetaminophen: 17 people, 73.91%
  2. Methylprednisolone Sodium Succinate: 11 people, 47.83%
  3. Methylprednisolone: 8 people, 34.78%
  4. Diphenhydramine Hydrochloride: 4 people, 17.39%
  5. Prednisone: 3 people, 13.04%
  6. Tacrolimus: 2 people, 8.70%
  7. Mycophenolate Mofetil: 2 people, 8.70%
  8. Cyclosporine: 2 people, 8.70%
  9. Cyclophosphamide: 2 people, 8.70%
  10. Vyvanse: 1 person, 4.35%

Common symptoms for these people *:

  1. Bladder Disorder: 17 people, 73.91%
  2. Night Sweats (sweating in night): 17 people, 73.91%
  3. High Blood Pressure: 5 people, 21.74%
  4. Fatigue (feeling of tiredness): 5 people, 21.74%
  5. Gingival Hyperplasia (overgrowth of gums): 4 people, 17.39%
  6. Excessive Or Unwanted Hair In Women: 4 people, 17.39%
  7. Cushingoid (obesity and weakening of the muscles): 4 people, 17.39%
  8. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 4 people, 17.39%
  9. Fever: 4 people, 17.39%
  10. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Arrhythmias:

All the conditions that are associated with Arrhythmias:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Arrhythmias and Focal segmental glomerulosclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: